Extended Infusion of Dexmedetomidine to an Infant at Sixty Times the Intended Rate
Dexmedetomidine is an 𝛼2 adrenergic agonist which has recently been approved in the United States for procedural sedation in adults. This report describes an infant who inadvertently received an intravenous infusion of dexmedetomidine at a rate which was 60 times greater than intended. We describe t...
Saved in:
| Main Authors: | Bryan A. Max, Keira P. Mason |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
Wiley
2010-01-01
|
| Series: | International Journal of Pediatrics |
| Online Access: | http://dx.doi.org/10.1155/2010/825079 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Effects of Dexmedetomidine-Fentanyl Infusion on Blood Pressure and Heart Rate during Cardiac Surgery in Children
by: Jyrson Guilherme Klamt, et al.
Published: (2010-01-01) -
Sixty Years at the Rega Institute
by: Erik De Clercq
Published: (2025-02-01) -
Bradycardia Leading to Asystole Following Dexmedetomidine Infusion during Cataract Surgery: Dexmedetomidine-Induced Asystole for Cataract Surgery
by: Amaniti Aikaterini, et al.
Published: (2018-01-01) -
Childhood adversity accelerates intended reproductive timing in adolescent girls without increasing interest in infants.
by: Stephanie Clutterbuck, et al.
Published: (2014-01-01) -
Sixty years of life with François Gros
by: Scherrer, Klaus
Published: (2023-12-01)